反射式共聚焦显微镜评估不可切除原发性皮肤黑色素瘤对免疫治疗的应答:2例报告
该病例报告于2017年3月至2018年6月纳入2例局部晚期黑色素瘤患者,分别接受帕博利珠单抗或伊匹木单抗-纳武利尤单抗联合治疗,用反射式共聚焦显微镜(RCM)监测皮肤病变,RCM所见与组织病理学相关,而磁共振成像和计算机断层扫描未显示应答。
要点
- RCM可显示免疫治疗后皮肤黑色素瘤基线清晰特征的消失,并与组织病理学相关。
- 影像学检查如磁共振成像和计算机断层扫描未显示皮肤病变的应答。
- RCM不会取代磁共振成像、正电子发射断层扫描和计算机断层扫描等大视野影像,但作为皮肤受累成像和疾病监测有前景。
核心结论
- RCM不会取代大视野影像(如磁共振成像、正电子发射断层扫描和计算机断层扫描)在黑色素瘤或其他肿瘤管理和随访中的作用,但对于皮肤受累成像和疾病监测,RCM作为一种新型无创技术有前景。
研究设计与样本
- 病例报告研究,2017年3月至2018年6月在一家三级癌症医院纳入2例局部晚期黑色素瘤患者,患者不适合手术或不愿手术,并开始免疫治疗方案。
主要发现
- 2例局部晚期黑色素瘤伴皮肤受累患者接受免疫治疗(1例帕博利珠单抗,另1例伊匹木单抗-纳武利尤单抗联合)后病变清除。
- RCM显示基线可见的清晰黑色素瘤特征消失,这些发现与组织病理学相关。
- 磁共振成像和计算机断层扫描等影像学图像未显示应答。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Melanoma incidence and the use of systemic treatments for it are rising. Current treatment monitoring uses clinical examination and radiologic examinations; however, cutaneous involvement and cutaneous metastasis may not be well visualized. Reflectance confocal microscopy (RCM) is a US Food and Drug Administration-approved, noninvasive technology that enables visualization of the skin with quasihistological resolution. OBJECTIVE: To evaluate the feasibility of using RCM to monitor advanced melanomas treated with immunotherapy. DESIGN, SETTING, AND PARTICIPANTS: This case report study took place from March 2017 to June 2018 and included 2 patients with locally advanced melanoma who were not candidates for surgery or were not willing to have surgery and who were started on an immunotherapy regimen at a tertiary care cancer hospital. MAIN OUTCOMES AND MEASURES: Clinical and RCM findings correlated with histopathology. RESULTS: In the patients, locally advanced melanoma with cutaneous involvement was treated with immunotherapy (pembrolizumab in 1 patient and an ipilimumab-nivolumab combination in the other) with resulting clearance of the lesions. Use of RCM showed the disappearance of clear melanoma features seen at baseline; these findings correlated with histopathology. The response was not seen with radiologic images, such as magnetic resonance imaging and computed tomography. CONCLUSIONS AND RELEVANCE: Although RCM will not replace larger field imaging (such as magnetic resonance imaging, positron emission tomography, and computed tomography) in the management and follow-up of melanoma or other tumors, for imaging of cutaneous involvement and disease monitoring, RCM holds promise as a novel noninvasive technique.
引用
- Navarrete-Dechent C, Cordova M, Postow MA, et al. Evaluation of the Response of Unresectable Primary Cutaneous Melanoma to Immunotherapy Visualized With Reflectance Confocal Microscopy: A Report of 2 Cases. JAMA Dermatol. 2019. PMID: 30624578. doi:10.1001/jamadermatol.2018.3688
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。